Interrupted Subdermal Suture Clinical Trial
Official title:
Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis: a Randomized Evaluator Blinded Split Wound Comparative Effectiveness Trial
| Verified date | June 2022 |
| Source | University of California, Davis |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study aims to investigate whether the spacing of the interrupted deep (subdermal) sutures affects surgical wound cosmesis on the trunk and extremities. In other words, the investigator would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated subdermal sutures or fewer, more widely spaced subdermal sutures. The investigator wishes to compare the effects of one versus two centimeter spacing between sutures.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | March 2, 2022 |
| Est. primary completion date | March 2, 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - 18 years of age or older - Able to give informed consent themselves - Patient scheduled for cutaneous surgical procedure on the trunk and extremities with predicted primary closure - Willing to return for follow up visit. Exclusion Criteria: - Mentally handicapped - Unable to understand written and oral English - Incarceration - Under 18 years of age - Pregnant Women - Wounds with predicted closure length less than 4 cm |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of California, Davis, Department of Dermatology | Sacramento | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, Davis |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Scar Assessment | The primary endpoint will be the score of two blinded reviewers using the patient observer scar assessment score. | 3 months following procedure | |
| Secondary | Width of Scar | A secondary endpoint will include the width of the scar 1 cm from midline on each side | 3 months following procedure | |
| Secondary | Erythema | If one half of the scar has more associated erythema, this will be noted | 3 months following procedure |